Titre : Vietnam

Vietnam : Questions médicales fréquentes

Termes MeSH sélectionnés :

Bone Density

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer la dengue au Vietnam ?

Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral.
Dengue Diagnostic médical
#2

Quels tests pour le paludisme au Vietnam ?

Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme.
Paludisme Tests de diagnostic
#3

Comment identifier la tuberculose ?

La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures.
Tuberculose Diagnostic médical
#4

Quels signes pour le choléra ?

Le choléra se diagnostique par des selles liquides et des tests de laboratoire.
Choléra Diagnostic médical
#5

Comment détecter une infection à VIH ?

Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH.
VIH Diagnostic médical

Symptômes 5

#1

Quels symptômes de la dengue ?

Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents.
Dengue Symptômes
#2

Quels signes du paludisme ?

Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques.
Paludisme Symptômes
#3

Quels symptômes de la tuberculose ?

Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants.
Tuberculose Symptômes
#4

Quels signes du choléra ?

Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques.
Choléra Symptômes
#5

Quels symptômes d'une infection à VIH ?

Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés.
VIH Symptômes

Prévention 5

#1

Comment prévenir la dengue ?

Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques.
Dengue Prévention
#2

Quelles mesures pour prévenir le paludisme ?

Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs.
Paludisme Prévention
#3

Comment prévenir la tuberculose ?

Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention.
Tuberculose Prévention
#4

Quelles précautions contre le choléra ?

Boire de l'eau potable, se laver les mains et consommer des aliments cuits.
Choléra Prévention
#5

Comment prévenir le VIH ?

Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH.
VIH Prévention

Traitements 5

#1

Quel traitement pour la dengue ?

Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate.
Dengue Traitement
#2

Comment traiter le paludisme ?

Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme.
Paludisme Traitement
#3

Quel traitement pour la tuberculose ?

La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois.
Tuberculose Traitement
#4

Comment traiter le choléra ?

Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire.
Choléra Traitement
#5

Quel traitement pour le VIH ?

Le VIH est traité par des antirétroviraux pour contrôler la charge virale.
VIH Traitement

Complications 5

#1

Quelles complications de la dengue ?

Les complications incluent la dengue sévère, le choc et des hémorragies.
Dengue Complications
#2

Quelles complications du paludisme ?

Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques.
Paludisme Complications
#3

Quelles complications de la tuberculose ?

Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments.
Tuberculose Complications
#4

Quelles complications du choléra ?

La déshydratation sévère peut entraîner un choc hypovolémique et la mort.
Choléra Complications
#5

Quelles complications du VIH ?

Le VIH peut mener à des infections opportunistes et à des cancers associés.
VIH Complications

Facteurs de risque 5

#1

Quels facteurs de risque pour la dengue ?

Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement.
Dengue Facteurs de risque
#2

Quels facteurs de risque pour le paludisme ?

Vivre dans des zones endémiques, absence de protection contre les moustiques.
Paludisme Facteurs de risque
#3

Quels facteurs de risque pour la tuberculose ?

Conditions de vie précaires, immunodépression et contact avec des malades.
Tuberculose Facteurs de risque
#4

Quels facteurs de risque pour le choléra ?

Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés.
Choléra Facteurs de risque
#5

Quels facteurs de risque pour le VIH ?

Relations sexuelles non protégées, partage de seringues et absence de dépistage.
VIH Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vietnam : Questions médicales les plus fréquentes", "headline": "Vietnam : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vietnam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-02-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vietnam" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Asie du Sud-Est", "url": "https://questionsmedicales.fr/mesh/D001210", "about": { "@type": "MedicalCondition", "name": "Asie du Sud-Est", "code": { "@type": "MedicalCode", "code": "D001210", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.252.145" } } }, "about": { "@type": "MedicalCondition", "name": "Vietnam", "alternateName": "Vietnam", "code": { "@type": "MedicalCode", "code": "D014744", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Pham Quang Thai", "url": "https://questionsmedicales.fr/author/Pham%20Quang%20Thai", "affiliation": { "@type": "Organization", "name": "National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam." } }, { "@type": "Person", "name": "Le Van Tan", "url": "https://questionsmedicales.fr/author/Le%20Van%20Tan", "affiliation": { "@type": "Organization", "name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam." } }, { "@type": "Person", "name": "Marc Choisy", "url": "https://questionsmedicales.fr/author/Marc%20Choisy", "affiliation": { "@type": "Organization", "name": "Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK." } }, { "@type": "Person", "name": "H Rogier van Doorn", "url": "https://questionsmedicales.fr/author/H%20Rogier%20van%20Doorn", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "H T Nguyen", "url": "https://questionsmedicales.fr/author/H%20T%20Nguyen", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluation of bone mineral density and bone turnover in children on anticoagulation.", "datePublished": "2023-08-01", "url": "https://questionsmedicales.fr/article/37600706", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1192670" } }, { "@type": "ScholarlyArticle", "name": "Intraoperative physician assessment of bone: correlation to bone mineral density.", "datePublished": "2023-03-31", "url": "https://questionsmedicales.fr/article/37000208", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00198-023-06729-3" } }, { "@type": "ScholarlyArticle", "name": "Influence of bone density on stability in TBW.", "datePublished": "2023-11-15", "url": "https://questionsmedicales.fr/article/37968632", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12891-023-07007-3" } }, { "@type": "ScholarlyArticle", "name": "[Bone mineral density in vegetarians and vegans].", "datePublished": "2023-04-17", "url": "https://questionsmedicales.fr/article/37432709", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.33029/0042-8833-2023-92-3-69-78" } }, { "@type": "ScholarlyArticle", "name": "Phthalates and bone mineral density: a systematic review.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36369032", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12940-022-00920-5" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Asie", "item": "https://questionsmedicales.fr/mesh/D001208" }, { "@type": "ListItem", "position": 4, "name": "Asie du Sud-Est", "item": "https://questionsmedicales.fr/mesh/D001210" }, { "@type": "ListItem", "position": 5, "name": "Vietnam", "item": "https://questionsmedicales.fr/mesh/D014744" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vietnam - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vietnam", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vietnam", "description": "Comment diagnostiquer la dengue au Vietnam ?\nQuels tests pour le paludisme au Vietnam ?\nComment identifier la tuberculose ?\nQuels signes pour le choléra ?\nComment détecter une infection à VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Bone+Density#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vietnam", "description": "Quels symptômes de la dengue ?\nQuels signes du paludisme ?\nQuels symptômes de la tuberculose ?\nQuels signes du choléra ?\nQuels symptômes d'une infection à VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Bone+Density#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vietnam", "description": "Comment prévenir la dengue ?\nQuelles mesures pour prévenir le paludisme ?\nComment prévenir la tuberculose ?\nQuelles précautions contre le choléra ?\nComment prévenir le VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Bone+Density#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vietnam", "description": "Quel traitement pour la dengue ?\nComment traiter le paludisme ?\nQuel traitement pour la tuberculose ?\nComment traiter le choléra ?\nQuel traitement pour le VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Bone+Density#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vietnam", "description": "Quelles complications de la dengue ?\nQuelles complications du paludisme ?\nQuelles complications de la tuberculose ?\nQuelles complications du choléra ?\nQuelles complications du VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Bone+Density#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vietnam", "description": "Quels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour le paludisme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le choléra ?\nQuels facteurs de risque pour le VIH ?", "url": "https://questionsmedicales.fr/mesh/D014744?mesh_terms=Bone+Density#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la dengue au Vietnam ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps ou l'ARN viral." } }, { "@type": "Question", "name": "Quels tests pour le paludisme au Vietnam ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un frottis sanguin ou un test de diagnostic rapide sont utilisés pour le paludisme." } }, { "@type": "Question", "name": "Comment identifier la tuberculose ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La tuberculose est diagnostiquée par des tests cutanés, des radiographies et des cultures." } }, { "@type": "Question", "name": "Quels signes pour le choléra ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra se diagnostique par des selles liquides et des tests de laboratoire." } }, { "@type": "Question", "name": "Comment détecter une infection à VIH ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques détectent les anticorps ou l'ARN du VIH." } }, { "@type": "Question", "name": "Quels symptômes de la dengue ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont fréquents." } }, { "@type": "Question", "name": "Quels signes du paludisme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont typiques." } }, { "@type": "Question", "name": "Quels symptômes de la tuberculose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, perte de poids, sueurs nocturnes et fatigue sont courants." } }, { "@type": "Question", "name": "Quels signes du choléra ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Diarrhée aqueuse sévère, vomissements et déshydratation rapide sont caractéristiques." } }, { "@type": "Question", "name": "Quels symptômes d'une infection à VIH ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes initiaux incluent fièvre, fatigue, éruptions cutanées et ganglions enflés." } }, { "@type": "Question", "name": "Comment prévenir la dengue ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques." } }, { "@type": "Question", "name": "Quelles mesures pour prévenir le paludisme ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des moustiquaires, des insecticides et prendre des médicaments préventifs." } }, { "@type": "Question", "name": "Comment prévenir la tuberculose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Vaccination BCG et dépistage des cas contacts sont essentiels pour la prévention." } }, { "@type": "Question", "name": "Quelles précautions contre le choléra ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Boire de l'eau potable, se laver les mains et consommer des aliments cuits." } }, { "@type": "Question", "name": "Comment prévenir le VIH ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des préservatifs et se faire dépister régulièrement pour prévenir le VIH." } }, { "@type": "Question", "name": "Quel traitement pour la dengue ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, avec des analgésiques et une hydratation adéquate." } }, { "@type": "Question", "name": "Comment traiter le paludisme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments antipaludiques comme l'artémisinine sont utilisés pour traiter le paludisme." } }, { "@type": "Question", "name": "Quel traitement pour la tuberculose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La tuberculose nécessite un traitement antibiotique prolongé, souvent sur six mois." } }, { "@type": "Question", "name": "Comment traiter le choléra ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra est traité par réhydratation orale ou intraveineuse et antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Quel traitement pour le VIH ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH est traité par des antirétroviraux pour contrôler la charge virale." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dengue sévère, le choc et des hémorragies." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le paludisme peut entraîner des anémies, des convulsions et des défaillances organiques." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la dissémination à d'autres organes et la résistance aux médicaments." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La déshydratation sévère peut entraîner un choc hypovolémique et la mort." } }, { "@type": "Question", "name": "Quelles complications du VIH ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le VIH peut mener à des infections opportunistes et à des cancers associés." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dengue ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones tropicales, exposition aux moustiques et manque d'assainissement." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le paludisme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre dans des zones endémiques, absence de protection contre les moustiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Conditions de vie précaires, immunodépression et contact avec des malades." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le choléra ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Accès limité à l'eau potable et à l'assainissement, ainsi que la consommation d'aliments contaminés." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le VIH ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Relations sexuelles non protégées, partage de seringues et absence de dépistage." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 06/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Pham Quang Thai

4 publications dans cette catégorie

Affiliations :
  • National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Viet Nam.

Le Van Tan

3 publications dans cette catégorie

Affiliations :
  • Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.

Marc Choisy

3 publications dans cette catégorie

Affiliations :
  • Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Centre for Global Health and Tropical Medicine, University of Oxford, UK.

H Rogier van Doorn

3 publications dans cette catégorie

Publications dans "Vietnam" :

H T Nguyen

3 publications dans cette catégorie

Publications dans "Vietnam" :

Peng An Khun

3 publications dans cette catégorie

Affiliations :
  • School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.

Long Duc Phi

3 publications dans cette catégorie

Affiliations :
  • Thai Binh University of Medicine and Pharmacy, Thai Binh, Viet Nam.

Deirdre A Collins

3 publications dans cette catégorie

Affiliations :
  • School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.

Thomas V Riley

3 publications dans cette catégorie

Affiliations :
  • School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia; Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia; PathWest Laboratory Medicine, Department of Microbiology, Nedlands, WA, Australia. Electronic address: thomas.riley@uwa.edu.au.

T T T Nguyen

2 publications dans cette catégorie

Affiliations :
  • Department of Organization and Drug Administration, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
Publications dans "Vietnam" :

My Hanh Bui

2 publications dans cette catégorie

Affiliations :
  • Hanoi Medical University, 1 Ton That Tung, Dong Da, Hanoi, 100000, Vietnam. buimyhanh@hmu.edu.vn.
  • Hanoi Medical University Hospital, 1 Ton That Tung, Dong Da, Hanoi, 100000, Vietnam. buimyhanh@hmu.edu.vn.
Publications dans "Vietnam" :

Quynh Long Khuong

2 publications dans cette catégorie

Affiliations :
  • Hanoi University of Public Health, 1A Duc Thang, North Tu Liem, Hanoi, 100000, Vietnam.
Publications dans "Vietnam" :

Hung N Luu

2 publications dans cette catégorie

Affiliations :
  • Division of Cancer Control and Population Sciences, University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
  • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
Publications dans "Vietnam" :

Marat T Makenov

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, 111123 Moscow, Russia.
Publications dans "Vietnam" :

Lan Anh T Le

2 publications dans cette catégorie

Affiliations :
  • Biomedicine Institute, Joint Vietnam-Russia Tropical Science and Technology Research Center, Hanoi 122000, Vietnam.
Publications dans "Vietnam" :

Ekaterina V Radyuk

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, 111123 Moscow, Russia.
Publications dans "Vietnam" :

Manh N Dao

2 publications dans cette catégorie

Affiliations :
  • Biomedicine Institute, Joint Vietnam-Russia Tropical Science and Technology Research Center, Hanoi 122000, Vietnam.
Publications dans "Vietnam" :

Chau V Nguyen

2 publications dans cette catégorie

Affiliations :
  • National Institute of Malariology, Parasitology and Entomology, Hanoi 110000, Vietnam.
Publications dans "Vietnam" :

Mo T Luong

2 publications dans cette catégorie

Affiliations :
  • Southern Branch of Joint Vietnam-Russia Tropical Science and Technology Research Center, Ho Chi Minh City 740500, Vietnam.
Publications dans "Vietnam" :

Victoria P Bulanenko

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Diagnostics and Epidemiology, Central Research Institute of Epidemiology, 111123 Moscow, Russia.
Publications dans "Vietnam" :

Sources (10000 au total)

Evaluation of bone mineral density and bone turnover in children on anticoagulation.

Childhood and adolescence are critical periods of bone mineral acquisition. Children on anticoagulation (AC) might have an increased risk for reduced bone mineral density (BMD). Risk factors for impai... To evaluate BMD in children on AC and characterize the risk factors of low BMD, including VK and Vitamin D (VD) status.... Single-center cross-sectional study of clinical, biochemical, and densitometric parameters. Assessment of VK surrogate parameters included ucOC and matrix gla protein (MGP).... A total of 39 children (4-18 years; 12 females) receiving AC were included, 31 (79%) on VK antagonists and 8 (21%) on direct oral anticoagulants. Overall, BMD was decreased for both the lumbar spine (... Our data indicate BMD reduction in pediatric patients on AC. Although AC-related factors did not predict reduced BMD, low BMI and pubertal stages represented important risk factors. Awareness of risk ...

Intraoperative physician assessment of bone: correlation to bone mineral density.

This study evaluated the intraoperative physician assessment (IPA) of bone status at time of total knee arthroplasty. IPA was highly correlated with distal femur and overall bone mineral density. When... Intuitively, intraoperative physician assessment (IPA) would be an excellent measure of bone status gained through haptic feedback during bone preparation. However, no studies have evaluated the ortho... Seventy patients undergoing TKA by 3 surgeons received pre-operative DXA. Intraoperatively, bone quality was assessed on a 5-point scale (1 excellent to 5 poor) based on tactile feedback to preparatio... The mean (SD) age and BMI were 65.8 (7.6) years and 31.4 (5.1) kg/m... IPA is highly correlated with local (distal femur) and overall BMD. This study supports the International Society for Clinical Densitometry position that surgeon concern regarding bone quality should ...

Phthalates and bone mineral density: a systematic review.

Exposure to endocrine disruptors, such as phthalates, may impact bone mineral density (BMD) through a variety of mechanisms. Studies of phthalate exposure and BMD in humans are scarce.... To synthesize published data on the association between phthalate metabolites and BMD in humans and to provide methodological suggestions for future research.... A single investigator searched PubMed for relevant studies, including observational studies of phthalate exposure and BMD in children and postmenopausal women. Twelve studies were screened with 5 meet... In one prospective study among postmenopausal women, higher levels of monocarboxyoctyl phthalate (MCOP) and monocarboxynonyl phthalate (MCNP) were significantly associated with lower BMD among nonuser... Studies among postmenopausal women provide suggestive evidence of an association between urinary phthalate metabolite concentration and decreased BMD. Results from studies of childhood BMD are inconcl...

Bone microstructure and volumetric bone mineral density in patients with global sagittal malalignment.

Sagittal spinal malalignment often leads to surgical realignment, which is associated with major complications. Low bone mineral density (BMD) and impaired bone microstructure are risk factors for ins... A retrospective, cross-sectional study of patients who underwent lumbar fusion for degeneration was conducted. The vBMD of the lumbar spine was assessed by quantitative computed tomography. Bone biops... A total of 172 patients (55.8% female, 63.3 years, BMI 29.7 kg/m... Sagittal malalignment is associated with lower lumbar vBMD and trabecular microstructure. Lumbar vBMD was significantly lower in patients with malalignment. These findings warrant attention, as malali...

Spine trabecular bone scores and bone mineral density of postmenopausal Taiwanese women.

The aims of the study were to determine the mean trabecular bone score (TBS) of postmenopausal Taiwanese women and to analyze the value of TBS in predicting osteoporosis.... A total of 1,915 postmenopausal women with lumbar spine and hip bone mineral density (BMD) and spine TBS were enrolled from a single medical center into this study. The women's BMD and TBS were measur... The average age of the women was 62.5 ± 9.1 years (range, 25.7-93.7 years). The mean TBS was 1.300 ± 0.086 (range, 1.015-1.596). The TBS was weakly and negatively correlated with body mass index ( r =... Bone mineral density and TBS can be used in combination to predict osteoporosis in a greater number of postmenopausal Taiwanese women. Because the incidence of osteoporosis is the highest among older ...

Diminished cortical bone density of long bones among children with haemophilic arthropathy.

Children with haemophilia (CwH) have lower bone mineral density in the spine (trabecular bone) than healthy children. There are few studies focusing on bone mineral density in long bones (cortical bon... To evaluate bi-laterally the distal third of radius and midshaft tibias using quantitative ultrasound (QUS) and assess the speed of sound (SoS).... A cross-sectional study where 91 CwH and 91 age-matched healthy boys were included. Joint evaluation was determined with the Haemophilia Joint Health Score 2.1 and SoS values. The Z scores were measur... Ninety-one CwH (haemophilia A) were evaluated (26 mild form, 26 moderate, and 39 severe). Most patients were treated with on-demand factor replacement and had higher total HJHS scores according to sev... There was diminished cortical bone density in radius and tibias of CwH compared to healthy controls. Changes predominated in tibias, more frequently affected according to the severity of haemophilia. ...

Association of Bone Mineral Density and Dementia: The Rotterdam Study.

Low bone mineral density (BMD) and dementia commonly co-occur in older individuals, with bone loss accelerating in patients with dementia due to physical inactivity and poor nutrition. However, uncert... In a prospective population-based cohort study, BMD at the femoral neck, lumbar spine, and total body and the trabecular bone score (TBS) were obtained using dual-energy X-ray absorptiometry in 3,651 ... Among the 3,651 participants (median age 72.3 ± 10.0 years, 57.9% women), 688 (18.8%) developed incident dementia during a median of 11.1 years, of whom 528 (76.7%) developed Alzheimer disease (AD). D... In conclusion, participants with low femoral neck and total body BMD and low TBS were more likely to develop dementia. Further studies should focus on the predictive ability of BMD for dementia....

Bone mineral density, vertebral fractures and trabecular bone score in primary ovarian insufficiency.

Bone health in primary ovarian insufficiency (POI) is under-investigated. We assessed patients with spontaneous POI for vertebral fractures (VFs) and related parameters of bone health.... 70 cases with spontaneous POI (age 32.5 ± 7.0 years) and an equal number of controls were assessed for BMD, TBS, and VFs. BMD at the lumbar-spine (L1-L4), left hip, non-dominant forearm, and TBS (iNsi... BMD at the lumbar-spine, hip and forearm was reduced by 11.5%, 11.4% and 9.1% in POI as compared to controls (P < 0.001). Degraded or partially degraded microarchitecture on TBS was observed in 66.7% ... Thus, lumbar-spine osteoporosis, impaired TBS and VFs were present in 35.7%, 66.7% and 15.7% of patients with spontaneous POI in their early third decade. This indicates need for rigorous investigatio...